DataMEDS AI, Inc. (MEDS) NASDAQ

Currency In USD

AD

Valuation

Market Cap28.37M
Enterprise Value53.09M
P/E Ratio-0.02
PEG Ratio0
Price/Sales Ratio0.51
Price/Book Ratio-0.12
Enterprise/Revenue4.27
Enterprise/EBITDA-0.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-11
Operating Margin-7.19
AD

Management Effectiveness

Return On Assets-2.69
Return On Equity8.78

Income Statement

Revenue23.34M
Revenue/Share3.12
Gross Profit-9.64M
EBITDA-93.48M
Net Income-101.27M
Diluted EPS-71.5

Balance Sheet

Total Cash2.46M
Total Cash/Share0.95
Total Debt32.62M
Total Debt/Equity-1.67
Current Ratio0.14
Book Value Per Share-7.58

Price History

52-Week Change-96.85
52-Week High35.5
52-Week Low0.82
Moving Average 50 Days2.48
Moving Average 200 Days5.12

Statistics

Average Volume6.53M
Shares Outstanding4.51M
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:50
Last Split DateMay 26, 2026
AD